Volume 35, No 12, Dec 2025

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 35 Issue 12, December 2025: 924-925

RESEARCH HIGHLIGHTS

CNS gatekeepers: IFNγ-activated dendritic cells control leptomeningeal metastasis

Alberto Hernández-Barranco^1,2,3 , Johanna A. Joyce^1,2,3,4,*

¹Department of Oncology, University of Lausanne, Lausanne, Switzerland
²Ludwig Institute for Cancer Research, Lausanne, Switzerland
³Agora Cancer Research Centre Lausanne, Lausanne, Switzerland
⁴L. Lundin and Family Brain Tumor Research Center, Departments of Oncology and Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Correspondence: Johanna A. Joyce(johanna.joyce@unil.ch)

Leptomeningeal metastasis (LM) arises in a specialized central nervous system niche where immune dynamics are poorly understood. Remsik et al. uncover a central role for IFNγ-activated dendritic cells in constraining LM growth, highlighting the need for immune-targeted therapies tailored to this unique compartment.

https://doi.org/10.1038/s41422-025-01144-1

FULL TEXT | PDF

Browse 243